Chemoinformaics analysis of cis-3-Hexenyl pentanoate
| Molecular Weight | 184.279 | nRot | 7 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 1 |
| Exact Molecular Weight | 184.146 | nRing | 0 |
| Solubility: LogS | -3.926 | nHRing | 0 |
| Solubility: LogP | 3.702 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.3099 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.455 |
| Synth | 1.812 |
| Natural Product Likeliness | 0.386 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.279 |
| MDCK | 0.0000297 |
| BBB | 0.916 |
| PPB | 0.840243 |
| VDSS | 0.634 |
| FU | 0.184339 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.308 |
| CYP2c19-inh | 0.75 |
| CYP2c19-sub | 0.573 |
| CYP2c9-inh | 0.642 |
| CYP2c9-sub | 0.681 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.089 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.208 |
| CL | 12.521 |
| T12 | 0.715 |
| hERG | 0.042 |
| Ames | 0.006 |
| ROA | 0.072 |
| SkinSen | 0.883 |
| Carcinogencity | 0.291 |
| EI | 0.988 |
| Respiratory | 0.163 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.726446 |